share_log

花旗:予阿里健康“买入”评级 目标价9.5港元

Citigroup: Buy rating on ali health with a target price of 9.5 Hong Kong dollars.

Sina Hong Kong Stocks ·  Nov 13 21:54

Citibank released a research report stating that ali health (00241) had a revenue increase of 10% year-on-year in the first half of fiscal 2025 to 14.3 billion yuan (same below), which is lower than the bank's expectations; net profit was 0.769 billion yuan, a year-on-year increase of 73%, exceeding the bank's expectations. The gross margin increased from 22.1% in the same period last year to 24.8% during the period, with the ratio of marketing and administration expenses slightly increasing to 8.2%. The bank's target price for the company is 9.5 HKD, with a rating of 'buy'.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment